Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Deciphering the Oncogenic Landscape: Unveiling the Molecular Machinery and Clinical Significance of Lncrna Tmpo-As1 in Human Cancers Publisher Pubmed



Saraswat SK1 ; Mahmood BS2 ; Ajila F3 ; Kareem DS4 ; Alwan M5 ; Athab ZH6 ; Shaier JB7 ; Hosseinifard SR8
Authors

Source: Pathology Research and Practice Published:2024


Abstract

The in-depth exploration of long non-coding RNAs (lncRNAs) reveals their pivotal and diverse roles in various disorders, particularly cancer. Within this intricate landscape, thymopoietin-antisense RNA-1 (TMPO-AS1) emerges as a noteworthy instigator of oncogenesis in humans. This exhaustive review seeks to intricately unravel the present understanding of TMPO-AS1, emphasizing its molecular foundations and highlighting its clinical applications in the realm of cancer research. TMPO-AS1 consistently exhibits heightened expression across a spectrum of cancer types, encompassing lung, colorectal, breast, cervical, bladder, pancreatic, hepatocellular, gastric, ovarian, and osteosarcoma. Elevated levels of TMPO-AS1 are intricately linked to unfavorable prognoses, accompanied by distinctive clinical and pathological characteristics. Functionally, TMPO-AS1 showcases its prowess in enhancing cancer cell migration, invasion, proliferation, and orchestrating epithelial-mesenchymal transition (EMT) through a myriad of molecular mechanisms. These mechanisms entail intricate interactions with proteins, microRNAs, and intricate signaling pathways. Furthermore, TMPO-AS1 is intricately involved in regulating critical cellular processes, including apoptosis and the cell cycle. The mounting evidence converges towards the potential of TMPO-AS1 serving as a diagnostic and prognostic biomarker, further entwined with its potential role in influencing chemoresistance in cancer. This potential is underscored by its consistent associations with clinical outcomes and treatment responses. This comprehensive investigation not only consolidates our existing knowledge of TMPO-AS1's multifaceted roles but also sheds illuminating insights on its profound significance in the intricate landscape of cancer biology, paving the way for potential applications in clinical practice. © 2024 Elsevier GmbH
Related Docs
View other Related Docs
1. An Overview of Long Noncoding Rnas: Biology, Functions, Therapeutics, Analysis Methods, and Bioinformatics Tools, Cell Biochemistry and Function (2022)
2. Heterogeneous Expression of Long Noncoding Rna Rp11-109D20.2: Insights Into Regulatory Gene Expression Roles in Colon Cancer, Iranian Journal of Basic Medical Sciences (2025)
3. The Role of Long Noncoding Rnas (Lncrnas) in the Pathogenesis of Chemoresistance in Endometrial Cancer: A Molecular Approach and Future Perspective, Indian Journal of Gynecologic Oncology (2025)
Experts (# of related papers)
View all Related Experts
Hamid Reza Mirzaei (1)
Masoomeh Safaei (1)
Other Related Docs
4. Cdkn2b-As1 As a Novel Therapeutic Target in Cancer: Mechanism and Clinical Perspective, Biochemical Pharmacology (2023)
5. Long Non-Coding Rnas (Lncrnas); Roles in Tumorigenesis and Potentials As Biomarkers in Cancer Diagnosis, Experimental Cell Research (2022)
6. Emerging Roles of Non-Coding Rnas in Modulating the Pi3k/Akt Pathway in Cancer, Non-coding RNA Research (2025)
7. Dysregulated Linc01133 Expression in Laryngeal Carcinoma: Prognostic Implications and Predicted Cerna Interactome, Molecular Biology Research Communications (2025)
8. Functions, Mechanisms, and Clinical Applications of Lncrna Linc00857 in Cancer Pathogenesis, Human Cell (2023)
9. Long Noncoding Rnas and Exosomal Lncrnas: Classification, and Mechanisms in Breast Cancer Metastasis and Drug Resistance, Oncogene (2020)
10. Gynecologic Cancers and Non-Coding Rnas: Epigenetic Regulators With Emerging Roles, Critical Reviews in Oncology/Hematology (2021)
11. Expression Analysis of Five Different Long Non-Coding Ribonucleic Acids in Nonsmall-Cell Lung Carcinoma Tumor and Tumor-Derived Exosomes, Diagnostics (2022)
12. A Systematic Review of Long Non-Coding Rnas With a Potential Role in Breast Cancer, Mutation Research - Reviews in Mutation Research (2021)
13. Lncrnas Roles in Chemoresistance of Cancer Cells, Current Molecular Medicine (2022)
14. Modulation of Long Non-Coding Rnas by Resveratrol As a Potential Therapeutic Approach in Cancer: A Comprehensive Review, Pathology Research and Practice (2023)
15. Up-Regulation of Foxn3-As1 in Invasive Ductal Carcinoma of Breast Cancer Patients, Heliyon (2021)
16. The Critical Role of Circular Rnas in Drug Resistance in Gastrointestinal Cancers, Medical Oncology (2023)
17. Down-Regulation of a Panel of Immune-Related Lncrnas in Breast Cancer, Pathology Research and Practice (2021)
18. A Comprehensive Review of the Role of Lncrnas in Gastric Cancer (Gc) Pathogenesis, Immune Regulation, and Their Clinical Applications, Pathology Research and Practice (2023)
19. The Expression of the Lncrnas Usp30-As1, Elfn1-As1, Gas8-As1, and Snhg11 in Breast Cancer Samples From Iranian Patients From 2014 to 2019: A Cross-Sectional Study, BMC Research Notes (2025)
20. Assessment of Sgo1 and Sgo1-As1 Contribution in Breast Cancer, Human Antibodies (2019)